DK0557876T3 - Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen - Google Patents
Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationenInfo
- Publication number
- DK0557876T3 DK0557876T3 DK93102450.9T DK93102450T DK0557876T3 DK 0557876 T3 DK0557876 T3 DK 0557876T3 DK 93102450 T DK93102450 T DK 93102450T DK 0557876 T3 DK0557876 T3 DK 0557876T3
- Authority
- DK
- Denmark
- Prior art keywords
- atoms
- treatment
- blood circulation
- radical
- muscle damage
- Prior art date
Links
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title abstract 2
- 208000029549 Muscle injury Diseases 0.000 title abstract 2
- 230000017531 blood circulation Effects 0.000 title abstract 2
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4205424 | 1992-02-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0557876T3 true DK0557876T3 (da) | 1997-05-26 |
Family
ID=6452327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93102450.9T DK0557876T3 (da) | 1992-02-22 | 1993-02-17 | Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0557876B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3193800B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR930017580A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE146078T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU658979B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2089959A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE59304710D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0557876T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2096115T3 (cg-RX-API-DMAC7.html) |
| GR (1) | GR3022183T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUT64472A (cg-RX-API-DMAC7.html) |
| TW (1) | TW288977B (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA931184B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3792266B2 (ja) * | 1994-06-16 | 2006-07-05 | 森精機興産株式会社 | 工作機械の熱変位補正方法及びその装置 |
| DE19540798A1 (de) * | 1995-11-02 | 1997-05-07 | Hoechst Ag | Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel |
| US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
| US20070105878A1 (en) * | 2005-10-03 | 2007-05-10 | Andrew Reaume | Purine formulations and methods for managing disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH608236A5 (cg-RX-API-DMAC7.html) * | 1974-01-22 | 1978-12-29 | Wuelfing J A Fa | |
| DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
| GB8621870D0 (en) * | 1986-09-11 | 1986-10-15 | Beecham Group Plc | Active compounds |
| EP0484785B1 (en) * | 1990-11-07 | 1996-05-22 | Hoechst-Roussel Pharmaceuticals Incorporated | Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses |
-
1993
- 1993-02-17 TW TW082101087A patent/TW288977B/zh active
- 1993-02-17 DK DK93102450.9T patent/DK0557876T3/da active
- 1993-02-17 AT AT93102450T patent/ATE146078T1/de not_active IP Right Cessation
- 1993-02-17 EP EP93102450A patent/EP0557876B1/de not_active Expired - Lifetime
- 1993-02-17 ES ES93102450T patent/ES2096115T3/es not_active Expired - Lifetime
- 1993-02-17 DE DE59304710T patent/DE59304710D1/de not_active Expired - Lifetime
- 1993-02-19 AU AU33761/93A patent/AU658979B2/en not_active Ceased
- 1993-02-19 ZA ZA931184A patent/ZA931184B/xx unknown
- 1993-02-19 JP JP02951693A patent/JP3193800B2/ja not_active Expired - Lifetime
- 1993-02-19 CA CA002089959A patent/CA2089959A1/en not_active Abandoned
- 1993-02-22 HU HU9300476A patent/HUT64472A/hu unknown
- 1993-02-22 KR KR1019930002426A patent/KR930017580A/ko not_active Withdrawn
-
1996
- 1996-12-30 GR GR960403651T patent/GR3022183T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9300476D0 (en) | 1993-05-28 |
| TW288977B (cg-RX-API-DMAC7.html) | 1996-10-21 |
| JP3193800B2 (ja) | 2001-07-30 |
| AU3376193A (en) | 1993-08-26 |
| EP0557876A1 (de) | 1993-09-01 |
| HUT64472A (en) | 1994-01-28 |
| CA2089959A1 (en) | 1993-08-23 |
| ZA931184B (en) | 1993-09-16 |
| DE59304710D1 (de) | 1997-01-23 |
| ATE146078T1 (de) | 1996-12-15 |
| ES2096115T3 (es) | 1997-03-01 |
| GR3022183T3 (en) | 1997-03-31 |
| KR930017580A (ko) | 1993-09-20 |
| AU658979B2 (en) | 1995-05-04 |
| JPH069634A (ja) | 1994-01-18 |
| EP0557876B1 (de) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK139287A (da) | Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler | |
| ES2150903T3 (es) | Derivados de 2-aralcoxi y 2-alcoxi adenosina de utilidad como vasodilatadores coronarios y como agentes antihipertensivos. | |
| SE9100342D0 (sv) | Novel steroid esters | |
| NO895273L (no) | Plantebeskyttende forbindelser, deres fremstilling og anvendelse. | |
| ATE73790T1 (de) | Amino 5,6,7,8tetrahydronaphtho(2,3b>furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ES2041246T3 (es) | Procedimiento para la reticulacion de organopolisiloxanos. | |
| FI894714A0 (fi) | Fluorsubstituerade benzenderivat. | |
| TW288977B (cg-RX-API-DMAC7.html) | ||
| DE69119700D1 (de) | Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren | |
| DE3855902D1 (de) | Herstellungsverfahren für 2,5-Diamino-6-nitro-pyridinderivate sowie neue 2,5-Diamino-6-nitro-pyridinderivate | |
| NZ216125A (en) | Isoxazoles and pharmaceutical compositions | |
| ATE18548T1 (de) | Pyrrolidin-derivate, herstellung und verwendung als heilmittel. | |
| ES2096800T3 (es) | Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos. | |
| DE3765206D1 (de) | Substituierte 2-aminotetraline. | |
| DK0424248T3 (da) | 20,21-dinoreburnamein med substitution i 15-stillingen, fremgangsmåde til deres fremstilling samt mellemprodukter til brug derved, deres anvendelse som lægemidler og præparater med indhold deraf | |
| ES436233A2 (es) | Procedimiento de preparacion de nuevos derivados de tetrahi-dro-m-oxazinas-sustituidas. | |
| FR2481697B1 (cg-RX-API-DMAC7.html) | ||
| RU93004489A (ru) | Лекарственное средство для профилактики и лечения повреждений мышц после прерывания кровообращения и способ лечения |